Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis (Q46851647)

25 December 2017

title

Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis (English)

1 reference

25 December 2017

1 reference

1 reference

11

Luyang Sun

1 reference

25 December 2017

Jing Liang

3

object named as

Jing Liang

1 reference

25 December 2017

Yongfeng Shang

12

object named as

Yongfeng Shang

1 reference

25 December 2017

author name string

Huijian Wu

1

1 reference

25 December 2017

Yupeng Chen

2

1 reference

25 December 2017

Bin Shi

4

1 reference

25 December 2017

Ge Wu

5

1 reference

25 December 2017

Ying Zhang

6

1 reference

25 December 2017

Dan Wang

7

1 reference

25 December 2017

Ruifang Li

8

1 reference

25 December 2017

Xia Yi

9

1 reference

25 December 2017

Hua Zhang

10

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

25 December 2017

published in

Nature

1 reference

25 December 2017

volume

438

1 reference

25 December 2017

page(s)

981-987

1 reference

25 December 2017

issue

7070

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1038/nature04225

exact match

0 references

cites work

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

Estrogens in the causation of breast, endometrial and ovarian cancers - evidence and hypotheses from epidemiological findings

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

Role of exogenous and endogenous hormones in endometrial cancer: review of the evidence and research perspectives

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

Endometrial adenocarcinoma: a primer for the generalist

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

Molecular basis of agonism and antagonism in the oestrogen receptor

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

Molecular determinants for the tissue specificity of SERMs

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

Discovery of estrogen receptor alpha target genes and response elements in breast tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

Genomic targets of nuclear estrogen receptors

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

Identification of estrogen-responsive genes by complementary deoxyribonucleic acid microarray and characterization of a novel early estrogen-induced gene: EEIG1.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

Novel estrogen and tamoxifen induced genes identified by SAGE (Serial Analysis of Gene Expression)

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

Regulation of estrogen target genes and growth by selective estrogen-receptor modulators in endometrial cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

The effects of estradiol and selective estrogen receptor modulators on gene expression and messenger RNA stability in immortalized sheep endometrial stromal cells and human endometrial adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

Estrogen receptor-mediated effects of tamoxifen on human endometrial cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

The Ishikawa Cells from Birth to the Present

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

Cloning and characterization of the human PAX2 promoter

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

Activation of kappa B-specific proteins by estradiol

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

Differential gene regulation by the SRC family of coactivators

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

Advances in chromatin remodeling and human disease

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

Agonistic effect of tamoxifen is dependent on cell type, ERE-promoter context, and estrogen receptor subtype: functional difference between estrogen receptors alpha and beta

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

Tamoxifen up-regulates oestrogen receptor-alpha, c-fos and glyceraldehyde 3-phosphate-dehydrogenase mRNAs in ovine endometrium.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

Activation of transcription by estrogen receptor alpha and beta is cell type- and promoter-dependent

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

In vivo regulation of syndecan-3 expression in the rat uterus by 17 beta-estradiol

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

Tamoxifen induction of angiogenic factor expression in endometrium

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

17 beta-estradiol- and 4-hydroxytamoxifen-induced transactivation in breast, endometrial and liver cancer cells is dependent on ER-subtype, cell and promoter context

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

Target specificity of selective estrogen receptor modulators within human endometrial cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

Differential SERM effects on corepressor binding dictate ERalpha activity in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

Activation of a Uterine Insulin-Like Growth Factor I Signaling Pathway by Clinical and Environmental Estrogens: Requirement of Estrogen Receptor-α

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

Combinatorial roles of the nuclear receptor corepressor in transcription and development

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

Antiestrogens: mechanisms and actions in target cells

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

Expression of the PAX2 oncogene in human breast cancer and its role in progesterone-dependent mammary growth

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

Hypomethylation distinguishes genes of some human cancers from their normal counterparts

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

The history of cancer epigenetics

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

Discovery of aberrant expression of R-RAS by cancer-linked DNA hypomethylation in gastric cancer using microarrays

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04225

7 January 2021

Identifiers

DOI

10.1038/NATURE04225

1 reference

25 December 2017

Dimensions Publication ID

0 references

1 reference

25 December 2017